Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes

被引:107
作者
Fernández-Torres, B
Cabañes, FJ
Carrillo-Muñoz, AJ
Esteban, A
Inza, I
Abarca, L
Guarro, J
机构
[1] Univ Rovira & Virgili, Fac Med, Unitat Microbiol, E-43201 Reus, Spain
[2] Univ Autonoma Barcelona, Fac Vet, Dept Sanitat & Anat Anim, Bellaterra, Spain
[3] Dept Microbiol Asesoria Cient & Invest Aplicada, Barcelona, Spain
关键词
D O I
10.1128/JCM.40.11.3999-4003.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
A multicenter study was conducted to define the most suitable testing conditions for antifungal susceptibility of dermatophytes. Broth microdilution MICs of clotrimazole, itraconazole, and terbinafine were determined in three centers against 60 strains of dermatophytes. The effects of inoculum density (ca. 10(3) and 10(4) CFU/ml), incubation time (3, 7, and 14 days), endpoint criteria for MIC determination (complete [MIC-0] and prominent [MIC-2] growth inhibition), and incubation temperature (28 and 37degreesC) on intra- and interlaboratory agreement were analyzed. The optimal testing conditions identified were an inoculum of 10(4) CFU/ml, a temperature of incubation of 28degreesC, an incubation period of 7 days, and MIC-0.
引用
收藏
页码:3999 / 4003
页数:5
相关论文
共 34 条
[1]
Alou Cervera L, 2001, Rev Esp Quimioter, V14, P340
[2]
In vitro activity of posaconazole against clinical isolates of dermatophytes [J].
Barchiesi, F ;
Arzeni, D ;
Camiletti, V ;
Simonetti, O ;
Cellini, A ;
Offidani, AM ;
Scalise, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (11) :4208-4209
[3]
Butty P, 1995, J MED VET MYCOL, V33, P403
[4]
de Hoog G.S., 2000, ATLAS CLIN FUNGI, VSecond
[5]
Pharmacokinetics of antifungal agents in onychomycoses [J].
Debruyne, D ;
Coquerel, A .
CLINICAL PHARMACOKINETICS, 2001, 40 (06) :441-472
[6]
Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection [J].
Denning, DW ;
Radford, SA ;
Oakley, KL ;
Hall, L ;
Johnson, EM ;
Warnock, DW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (03) :401-414
[7]
Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.:: NCCLS collaborative evaluation [J].
Espinel-Ingroff, A ;
Bartlett, M ;
Chaturvedi, V ;
Ghannoum, M ;
Hazen, KC ;
Pfaller, MA ;
Rinaldi, M ;
Walsh, TJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1828-1835
[8]
Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi [J].
Espinel-Ingroff, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) :1360-1367
[9]
COMPARATIVE AND COLLABORATIVE EVALUATION OF STANDARDIZATION OF ANTIFUNGAL SUSCEPTIBILITY TESTING FOR FILAMENTOUS FUNGI [J].
ESPINELINGROFF, A ;
DAWSON, K ;
PFALLER, M ;
ANAISSIE, E ;
BRESLIN, B ;
DIXON, D ;
FOTHERGILL, A ;
PAETZNICK, V ;
PETER, J ;
RINALDI, M ;
WALSH, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :314-319
[10]
Comparison of two methods for antifungal susceptibility testing of Trichophyton rubrum [J].
Fernández-Torres, B ;
Pereiro, M ;
Guarro, J .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2002, 21 (01) :70-71